Tobacco Control

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Tobacco Control 2006;15(Supplement 4 ):iv68-iv76; doi:10.1136/tc.2005.014241
Copyright © 2006 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Francis, J. A
Right arrow Articles by Samet, J. M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Francis, J. A
Right arrow Articles by Samet, J. M
Related Collections
Right arrow Environmental tobacco smoke

RESEARCH PAPER

Challenging the epidemiologic evidence on passive smoking: tactics of tobacco industry expert witnesses

John A Francis, Amy K Shea, Jonathan M Samet*

Institute for Global Tobacco Control, Johns Hopkins School of Public Health, Baltimore, Maryland, USA

Correspondence to:
Professor Jonathan M Samet
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 N. Wolfe Street, Suite W6041, Baltimore, MD 21205, USA; jsamet{at}jhsph.edu

Objective: To analyse the statements given by tobacco industry defence witnesses during trial testimonies and depositions in second-hand smoke cases and in parallel, to review criticisms of epidemiology in industry-funded publications in order to identify strategies for discrediting epidemiologic evidence on passive smoking health effects.

Methods: A collection of depositions and trial testimony transcripts from tobacco industry-related lawsuits filed in the United States during the 1990s, was compiled and indexed by the Tobacco Deposition and Trial Testimony Archive (DATTA). Statements in DATTA made by expert witnesses representing the tobacco industry relating to the health effects of passive smoking were identified and reviewed. Industry-supported publications within the peer-reviewed literature were also examined for statements on exposure misclassification, meta-analysis, and confounding.

Results: The witnesses challenged causation of adverse health effects of passive smoking by citing limitations of epidemiologic research, raising methodological and statistical issues, and disputing biological plausibility. Though not often cited directly by the witnesses, the defence tactics mirrored the strategies used in industry-funded reports in the peer-reviewed literature.

Conclusion: The tobacco industry attempted to redirect the focus and dialogue related to the epidemiologic evidence on passive smoking. This approach, used by industry experts in trial testimony and depositions, placed bias as a certain alternative to causation of diseases related to passive smoking and proposed an unachievable standard for establishing the mechanism of disease.


Abbreviations: CIAR, Center for Indoor Air Research; DATTA, Tobacco Deposition and Trial Testimony Archive; EPA, Environmental Protection Agency; ETS, environmental tobacco smoke; IARC, International Agency for Research on Cancer; NHANES, National Health and Nutrition Examination Survey; ORNL, Oak Ridge National Laboratory; OSHA, Occupational Safety and Health Administration

Keywords: tobacco industry; passive smoking; environmental tobacco smoke; ETS




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
K. Narkiewicz
Second-hand smoke--a license to kill due to expire
Nephrol. Dial. Transplant., June 1, 2007; 22(6): 1508 - 1511.
[Full Text] [PDF]


Home page
Tobacco ControlHome page
D D. Blanke and H. H Humphrey III
Putting truth into action: using the evidence for justice
Tob. Control, December 1, 2006; 15(suppl_4): iv1 - iv3.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 by the BMJ Publishing Group Ltd.